Lenil Antimicotico

Clotrimazole, the active ingredient in Lenil Antimicotico, is an imidazole antifungal presented as a topical formulation for skin use. It treats superficial fungal infections such as tinea and cutaneous candidiasis in adults and children when appropriate. GNH USA supplies Lenil Antimicotico as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lenil Antimicotico contains clotrimazole, an imidazole antifungal that acts on dermatophyte and yeast infections of the skin. - Tinea corporis (ringworm of the body): reduces fungal growth and clears the rash. - Tinea pedis (athlete's foot): alleviates itching, scaling and erythema. - Cutaneous candidiasis: eradicates Candida species on the skin and restores normal appearance.

Clotrimazole is generally well tolerated when applied to intact skin, but local reactions can occur.

Common Side Effects: - Burning sensation at the application site. - Mild itching or pruritus. - Redness or erythema. - Dryness or peeling of the skin. - Local rash or irritation.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling and blistering. - Severe skin reactions such as Stevens‑Johnson syndrome (very rare). - Systemic absorption leading to liver enzyme abnormalities (extremely rare). - Widespread rash extending beyond the treated area. - Persistent edema or urticaria.

Before using Lenil Antimicotico, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: avoid application to broken skin and discuss with a provider. - Age: not recommended for infants under one month of age. - Concomitant topical steroids: may increase systemic absorption; monitor for irritation. - Allergy: discontinue use if signs of hypersensitivity develop. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Clotrimazole may interact with other topical agents or systemic antifungals.

Major Interactions (Avoid): - Concurrent use of systemic azole antifungals: may increase systemic exposure. - Combined topical ketoconazole: additive irritation risk. - Alcohol‑based skin cleansers: can enhance local irritation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may alter clotrimazole absorption. - Occlusive dressings: increase drug penetration and potential irritation.